Testing a new medicine for vitiligo (white patches on skin)
This study tests an experimental medicine (called EB06) to see if it can help bring back skin color in people with vitiligo. If you join, you'll either get the medicine or a dummy pill, and the study will track your progress over about 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have non-segmental vitiligo (white patches on both sides of your body)
- At least 5% of your body has white patches, including some on your face
- You can stop using other vitiligo treatments (like creams, light therapy, pills) during the study
- You are willing to use birth control during the study if needed
- You have not had cancer in the last 5 years (except some harmless skin cancers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called LY4005130 for non-segmental vitiligo, a skin condition where patches lose pigment (color). The trial aims to see if this drug can help restore skin color and stop the spread of white patches.
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
This trial tests an oral medication (a tablet) for treating non-segmental vitiligo, a condition where white patches appear on the skin. The goal is to see if the drug can safely help bring color back to those patches.
This study tests a new drug called EI-001 for people with non-segmental vitiligo (a type where white patches appear on both sides of the body). It is for those whose vitiligo has not gotten better with standard treatments like creams or light therapy, or who cannot use those treatments.
This study tests an experimental medication (ACT-777991) taken by mouth to see if it can help repigment skin in adults with non-segmental vitiligo. It aims to learn how safe it is and how well it works.
This study tests an investigational drug (GIA632) in people with non-segmental vitiligo. It aims to see if different doses can safely and effectively restore color to white patches.
Hear when a new Non-Segmental Vitiligo (NSV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.